PAPER Valipour M, Davaji I, Abedi N, Rajabi M, Küçükkılınç TT, Ayazgök B, Irannejad H
SEARCH RESULTS
1477 RESULTS
PAPER Torso M, Bozzali M, Cercignani M, Jenkinson M, Chance SA
Using diffusion tensor imaging to detect cortical changes in fronto-temporal dementia subtypes.
Sci Rep. 2020 Jul 8;10(1):11237. PubMed: 32641807PAPER Yoo SJ, Son G, Bae J, Kim SY, Yoo YK, Park D, Baek SY, Chang KA, Suh YH, Lee YB, Hwang KS, Kim Y, Moon C
Longitudinal profiling of oligomeric Aβ in human nasal discharge reflecting cognitive decline in probable Alzheimer's disease.
Sci Rep. 2020 Jul 8;10(1):11234. PubMed: 32641719PAPER Massimi L, Pieroni N, Maugeri L, Fratini M, Brun F, Bukreeva I, Santamaria G, Medici V, Poloni TE, Balducci C, Cedola A
Assessment of plaque morphology in Alzheimer's mouse cerebellum using three-dimensional X-ray phase-based virtual histology.
Sci Rep. 2020 Jul 8;10(1):11233. PubMed: 32641715PAPER Switzer AR, Cheema I, McCreary CR, Zwiers A, Charlton A, Alvarez-Veronesi A, Sekhon R, Zerna C, Stafford RB, Frayne R, Goodyear BG, Smith EE
Cerebrovascular reactivity in cerebral amyloid angiopathy, Alzheimer disease, and mild cognitive impairment.
Neurology. 2020 Sep 8;95(10):e1333-e1340. Epub 2020 Jul 8 PubMed: 32641520PAPER Schumacher J, Taylor JP, Hamilton CA, Firbank M, Cromarty RA, Donaghy PC, Roberts G, Allan L, Lloyd J, Durcan R, Barnett N, O'Brien JT, Thomas AJ
Quantitative EEG as a biomarker in mild cognitive impairment with Lewy bodies.
Alzheimers Res Ther. 2020 Jul 8;12(1):82. PubMed: 32641111PAPER Montero-Odasso M, Ismail Z, Livingston G
One third of dementia cases can be prevented within the next 25 years by tackling risk factors. The case "for" and "against".
Alzheimers Res Ther. 2020 Jul 8;12(1):81. PubMed: 32641088PAPER Nakanishi H, Nonaka S, Wu Z
Microglial Cathepsin B and Porphyromonas gingivalis Gingipains as Potential Therapeutic Targets for Sporadic Alzheimer's Disease.
CNS Neurol Disord Drug Targets. 2020;19(7):495-502. PubMed: 32640970PAPER Kumar R, Gulati M, Singh SK, Sharma D, Porwal O
Road From Nose to Brain for Treatment of Alzheimer: The Bumps and Humps.
CNS Neurol Disord Drug Targets. 2020 Jul 8; PubMed: 32640969PAPER Farkhondeh T, Khan H, Aschner M, Samini F, Pourbagher-Shahri AM, Aramjoo H, Roshanravan B, Hoyte C, Mehrpour O, Samarghandian S
Impact of Cannabis-Based Medicine on Alzheimer's Disease by Focusing on the Amyloid β-Modifications: A Systematic Study.
CNS Neurol Disord Drug Targets. 2020;19(5):334-343. PubMed: 32640965PAPER Santaniello A, Garzillo S, Amato A, Sansone M, Di Palma A, Di Maggio A, Fioretti A, Menna LF
Animal-Assisted Therapy as a Non-Pharmacological Approach in Alzheimer's Disease: A Retrospective Study.
Animals (Basel). 2020 Jul 6;10(7) PubMed: 32640648PAPER Schreiber S, DiFrancesco JC
Impaired occipital cerebrovascular reactivity as a biomarker for vascular β-amyloid.
Neurology. 2020 Sep 8;95(10):415-416. Epub 2020 Jul 8 PubMed: 32641536PAPER Yim D, Yeo TY, Park MH
Mild cognitive impairment, dementia, and cognitive dysfunction screening using machine learning.
J Int Med Res. 2020 Jul;48(7):300060520936881. PubMed: 32644870PAPER Fong ZH, Tan SH, Mahendran R, Kua EH, Chee TT
Arts-based interventions to improve cognition in older persons with mild cognitive impairment: A systematic review of randomized controlled trials.
Aging Ment Health. 2020 Jul 8;:1-13. PubMed: 32643397PAPER Chen SJ, Lee BC, Lee NC, Chien YH, Hwu WL, Lin CH
Clinical, radiological, and genetic characteristics in patients with Huntington's disease in a Taiwanese cohort.
Am J Med Genet B Neuropsychiatr Genet. 2020 Sep;183(6):352-359. Epub 2020 Jul 9 PubMed: 32643304Current Filters
- Date Range : Jun 2020 to Jul 2020 x